1. Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a. Issue 6 (18th December 2020) Authors: Shachar, Shlomit S; Deal, Allison M; Reeder-Hayes, Katherine E; Nyrop, Kirsten A; Mitin, Natalia; Anders, Carey K; Carey, Lisa A; Dees, E Claire; Jolly, Trevor A; Kimmick, Gretchen G; Karuturi, Meghan S; Reinbolt, Raquel E; Speca, JoEllen C; Muss, Hyman B Journal: JNCI cancer spectrum Issue: Volume 4:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Issue 2 (4th February 2022) Authors: Anders, Carey K; Woodcock, Mark G; Van Swearingen, Amanda E D; Moore, Dominic T; Sambade, Maria J; Laurie, Sonia; Robeson, Alexander; Kolupaev, Oleg; Cuaboy, Luz A; Garrett, Amy L; McKinnon, Karen; Cowens, Kristen; Bortone, Dante; Calhoun, Benjamin C; Wilkinson, Alec D; Carey, Lisa; Jolly, Trevor... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INNV-35. ROUTINE SEQUENCING OF BRAIN TUMORS UNCOVERS HIGH RATES OF ACTIONABLE OPPORTUNITIES: THE UNC EXPERIENCE. (5th November 2018) Authors: Khagi, Simon; Dees, E Claire; Bell, Emily; Pietrosimone, Kathryn; Garrett, Amy Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. Issue 4 (April 2015) Authors: Melichar, Bohuslav; Adenis, Antoine; Lockhart, A Craig; Bennouna, Jaafar; Dees, E Claire; Kayaleh, Omar; Obermannova, Radka; DeMichele, Angela; Zatloukal, Petr; Zhang, Bin; Ullmann, Claudio Dansky; Schusterbauer, Claudia Journal: Lancet oncology Issue: Volume 16:Issue 4(2015:Apr.) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. Issue 4 (April 2015) Authors: Melichar, Bohuslav; Adenis, Antoine; Lockhart, A Craig; Bennouna, Jaafar; Dees, E Claire; Kayaleh, Omar; Obermannova, Radka; DeMichele, Angela; Zatloukal, Petr; Zhang, Bin; Ullmann, Claudio Dansky; Schusterbauer, Claudia Journal: Lancet oncology Issue: Volume 16:Issue 4(2015:Apr.) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗